TGFB1 and Alzheimer disease: Notably, numerous studies have shown that the TGF-β1 signaling pathway is selectively impaired in the early stages of AD, leading to microglia activation, neuroinflammation, increased neuronal vulnerability to Aβ oligomers, hippocampal atrophy, and cognitive decline [121, 124].